AlphaStocks
4.3
Weak

Sabra Health Care REIT, Inc. (SBRA)

As of Sep 19, 2026, Sabra Health Care REIT, Inc. (SBRA) scores 4.3/10 on AlphaStocks' five-model composite, #63 of 104 Real Estate stocks. At $20, SBRA trades 12% below its model fair value of $22.

Real Estate / Health Care REITs

S&P MidCap 400

$19.76

Below average on several measures. Research carefully.

Weak

Score based on 5 of 5 models — high confidence

Data as of Sep 19, 2026

#63out of 104 in Real Estate

Is Sabra Health Care REIT, Inc. a Good Investment in 2026?

Sabra Health Care REIT, Inc. (SBRA) scores 4.3 out of 10 on AlphaStocks' composite model, earning a Weak rating. The Buffett model rates Sabra Health Care REIT, Inc. as Attractive. However, the Greenblatt Magic Formula model rates it Caution — Earnings yield 2.0% · ROC 3%. Sabra Health Care REIT, Inc. currently trades 12% below its estimated fair value of $22. Sabra Health Care REIT, Inc. ranks #63 out of 104 stocks in the Real Estate sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E31.1ROE5.5Market Cap5BDiv Yield6.0

Estimated Fair Value

$22.4612% below

Trading below estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Neutral

4/8

Buffett

Attractive

Business quality & competitive moat

Graham

Attractive

Significantly above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Caution

Earnings yield 2.0% · ROC 3%

Frequently Asked Questions

Is Sabra Health Care REIT, Inc. (SBRA) a good investment?
As of Sep 19, 2026, Sabra Health Care REIT, Inc. (SBRA) scores 4.3/10 on AlphaStocks' five-model composite, #63 of 104 Real Estate stocks. At $20, SBRA trades 12% below its model fair value of $22. That score is below average, suggesting caution.
What is Sabra Health Care REIT, Inc.'s Piotroski F-Score?
Sabra Health Care REIT, Inc.'s Piotroski F-Score status is Neutral. The raw score is 4/8. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is SBRA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $22, SBRA appears undervalued. The stock currently trades 12% below its estimated fair value. Trading below estimated fair value.
How does SBRA compare to other Real Estate stocks?
Sabra Health Care REIT, Inc. ranks #63 out of 104 stocks in the Real Estate sector, placing it in the top 61% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about SBRA?
AlphaStocks evaluates SBRA using five proven investment models. Piotroski: Neutral; Buffett: Attractive; Graham: Attractive; Lynch: Neutral; Greenblatt Magic Formula: Caution. These models are combined into a single composite score of 4.3/10.

Similar Stocks

Compare SBRA with

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer